Conning Inc’s Silo Pharma SILO Stock Holding History

Conning Inc’s Portfolio SILO Stock Details SILO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,333	Closed	-$23.4K	–	358
2025 Q1	$23.4K	Buy	+1,333	New	+$29.8K	﹤0.01%	351

Other funds holding SILO

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UFM

Ursa Fund Management Danville, California $108M AUM 30.27% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Conning Inc's SILO Position: Q2 2025 in Review

Conning Inc sold out of Silo Pharma (SILO) in Q2 2025, closing a stake of 1,333 shares — an estimated $23.4K sold.

Conning Inc first reported a position in SILO in Q1 2025 and held it in 1 quarter. The position peaked at $23.4K in Q1 2025. 13 funds tracked by Wall St. Rank hold SILO as of Q2 2025.

Conning Inc reported no remaining Silo Pharma position as of Q2 2025 after selling out during the quarter.
Conning Inc sold 1,333 Silo Pharma shares in Q2 2025, an estimated $23.4K.
Conning Inc first reported a position in Silo Pharma in Q1 2025 and held it in 1 quarter.
Conning Inc's Silo Pharma position peaked at $23.4K in Q1 2025.
13 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2025.

Based on Conning Inc's 13F filing for Q2 2025, filed 24 Jul 2025.